Revision to Prior Period Financial Statements (Tables)

3 Months Ended

Mar. 31, 2021

Revision to Prior Period Financial Statements

Summarizes the effect of the restatement on financial statement

	As of January 8, 2021
	As Previously
	Reported		Adjustment		As Revised
Balance Sheet
Total assets	$	243,126,571	$	—	$	243,126,571
Liabilities and shareholders’ equity
Total current liabilities	$	729,654	$	—	$	729,654
Deferred underwriting commissions		8,400,000		—		8,400,000
Derivative warrant liabilities		—		19,300,000		19,300,000
Total liabilities		9,129,654		19,300,000		28,429,654
Class A ordinary shares, $0.0001 par value; shares subject to possible redemption		228,996,910		(19,300,000)		209,696,910
Stockholders’ equity
Preference shares - $0.0001 par value		—		—		—
Class A ordinary shares - $0.0001 par value		110		629		739
Class B ordinary shares - $0.0001 par value		690		—		690
Additional paid-in-capital		5,040,235		677,251		5,717,486
Accumulated deficit		(41,028)		(677,880)		(718,908)
Total shareholders’ equity		5,000,007		—		5,000,007
Total liabilities and shareholders’ equity	$	243,126,571	$	—	$	243,126,571